Helicobacter Pylori Testing Market worth over $560mn by 2025

Helicobacter Pylori Testing Market size is set to surpass USD 560 million by 2025, according to a new research report by Global Market Insights, Inc.
 

Innovations and technological advancements in helicobacter pylori infection (H. pylori infection) testing results in greater consumer satisfaction that will accelerate the market growth. H. pylori is found in 50-80% of patients suffering with gastric ulcers and in 90% of patients with duodenal ulcers. Hence, rising prevalence of these symptoms will fuel the market expansion. Moreover, growing demand for diagnostics at relatively lower prices will augment the market progression during the forecast period.



Request Sample Buy NowInquiry Before Buying
 

 

Rise in adoption of non-invasive methods will remain a key growth driver

The upsurge in prevalence of H. pylori infection, rise in demand for early detection of disorders such as peptic ulcer, gastric cancer and innovation in diagnostic techniques will further foster the market of H. pylori testing. The increase in availability of affordable non-invasive tests is expected to increase the diagnosis, that in turn will boost the industry growth in the coming years. However, competitive pricing pressure due to presence of highly major companies may hinder the industry expansion.
 

Stool antigen test to attain new heights in non-invasive testing market

The non-invasive testing segment will reach USD 319.4 million by 2025. Advancement in non-invasive testing for H. Pylori infections has greatly contributed to development of stool antigen diagnosis kits. In the U.S., 20% of the population under 30 and 50% of the population over 60 are infected with H. pylori. H. pylori can lead to serious sub-clinical infections. As noted in the ACG 2017 guidelines, stool antigen testing provides accurate detection of active H. pylori infection before and after treatment.
 

Browse key industry insights spread across 180 pages with 162 market data tables & 09 figures & charts from the report, “Helicobacter Pylori Testing Market Size By Test Type (Invasive {Histology, Rapid Urease Test (RUT), HP Culture}, Non-Invasive {Serologic Test, Urea Breath Test (UBT), Stool Antigen Test (SAT)}), By Method (Point Of Care (POC) Test, Laboratory Based Test), By End-use (Hospitals, Clinics, Diagnostic Laboratories), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/helicobacter-pylori-testing-market
 

Laboratory-based test to reflect a positive growth trajectory

Laboratory based tests segment is estimated to register growth of more than 6.8% through 2025. The laboratory-based H. pylori test are high volume test. Invasive tests such as histology, rapid urea test, culture etc. are majorly performed in laboratories as these tests requires biopsies. The segment growth can be attributed to the availability of laboratories, presence of skilled lab professionals and well-developed infrastructure.
 

Diagnostic laboratories continue to dominate the overall market value

In 2018, the diagnostic laboratories segment held a largest market share of the market owing to presence of well-established labs and increasing number of tests carried out in labs. 
 

Europe region is set to proceed swiftly due to increasing acceptance of advanced technologies

Europe helicobacter pylori testing market will showcase significant growth during the forecast timeframe. The easy availability of test kits and government support are few factors that are contributing towards revenue growth of market. Rising support of government for eradication of Helicobacter pylori will further aid in eliminating the risk of gastric cancer. Additionally, existence of notable business players, and strategic initiatives in region will contribute to the market demand. For instance, in October 2018, DiaSorin Inc., an Italian-based firm strategically collaborated with Meridian Bioscience, Inc. to sell DiaSorin’s Helicobacter pylori stool antigen test to detect infection on its automated LIAISON platform. Moreover, technology penetration is comparatively higher in the Europe that positively impacts the regional growth.
 

Market players majorly adopt collaboration strategies to sustain the business competition

Escalating demand for adoption of advanced technologies coupled with rising number of firms offering innovative H. pylori testing solutions will impel the industry progression. Few of the prominent participants operating in the market are Abbott, Bio-Rad Laboratories, Inc., Cardinal Health, Quidel Corporation, Meridian Biosciences and Thermo Fisher. Market leaders are involved in various strategic alliances such as mergers & acquisitions, partnerships, and collaborations with other contributors to acquire significant revenue shares and competitive advantage over the other industry players.

 

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X